Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 21 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 8,797,833 | reported | 17 Oct 2025 | tx 7+1,708,390 |
| TScan Therapeutics, Inc. | 8,019,148 | reported | 23 Dec 2025 | tx 9+7,750,595−25,400 |
| Neuphoria Therapeutics Inc. | 875,328 | reported | 21 Oct 2025 | tx 1+639,110 |
| Passage BIO, Inc. | 591,696 | reported | 24 Jul 2025 | tx 7+958,846 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Dec 2025 | PURCHASE | TScan Therapeutics, Inc. | 80,069 | 0.90 USD | |
| 23 Dec 2025 | PURCHASE | TScan Therapeutics, Inc. | 6,232 | 0.90 USD | |
| 22 Dec 2025 | PURCHASE | TScan Therapeutics, Inc. | 75,500 | 0.90 USD | |
| 21 Oct 2025 | PURCHASE | Neuphoria Therapeutics Inc. | 639,110 | 5.14 USD | |
| 15 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 51,500 | 7.94 USD | |
| 16 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 150,000 | 8.86 USD | |
| 17 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 32,217 | 7.84 USD | |
| 14 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 15,032 | 7.59 USD | |
| 08 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 556,300 | 6.46 USD | |
| 09 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 626,043 | 6.70 USD | |
| 10 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 277,298 | 7.36 USD | |
| 24 Jul 2025 | PURCHASE | Passage BIO, Inc. | 66,423 | 5.71 USD | |
| 22 Jul 2025 | PURCHASE | Passage BIO, Inc. | 13,123 | 5.44 USD | |
| 23 Jul 2025 | PURCHASE | Passage BIO, Inc. | 49,302 | 5.74 USD | |
| 20 May 2025 | PURCHASE | TScan Therapeutics, Inc. | 1,200,000 | 1.20 USD | |
| 19 May 2025 | PURCHASE | TScan Therapeutics, Inc. | 1,388,794 | 1.20 USD | |
| 27 Dec 2024 | PURCHASE | Passage BIO, Inc. | 373,645 | 0.65 USD | |
| 25 Nov 2024 | PURCHASE | Passage BIO, Inc. | 259,998 | 0.56 USD | |
| 27 Nov 2024 | PURCHASE | Passage BIO, Inc. | 29,300 | 0.67 USD | |
| 26 Nov 2024 | PURCHASE | Passage BIO, Inc. | 167,055 | 0.71 USD | |
| 19 Apr 2024 | PURCHASE | TScan Therapeutics, Inc. | 5,000,000 | 7.13 USD | deriv |
| 31 May 2023 | SALE | TScan Therapeutics, Inc. | 400 | 2.51 USD | |
| 31 May 2023 | SALE | TScan Therapeutics, Inc. | 10,000 | 2.51 USD | |
| 31 May 2023 | SALE | TScan Therapeutics, Inc. | 15,000 | 2.52 USD |